Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Sanara MedTech (SMTI) Debt to Equity (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Debt to Equity for 12 consecutive years, with $7.33 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Debt to Equity rose 22834.29% year-over-year to $7.33, compared with a TTM value of $7.33 through Sep 2025, up 22834.29%, and an annual FY2024 reading of $0.03, down 44.77% over the prior year.
  • Debt to Equity was $7.33 for Q3 2025 at Sanara MedTech, up from $0.03 in the prior quarter.
  • Across five years, Debt to Equity topped out at $7.33 in Q3 2025 and bottomed at $0.03 in Q4 2024.
  • Average Debt to Equity over 3 years is $0.89, with a median of $0.05 recorded in 2023.
  • Peak annual rise in Debt to Equity hit 22834.29% in 2025, while the deepest fall reached 90.88% in 2025.
  • Year by year, Debt to Equity stood at $0.06 in 2023, then tumbled by 44.77% to $0.03 in 2024, then surged by 23372.71% to $7.33 in 2025.
  • Business Quant data shows Debt to Equity for SMTI at $7.33 in Q3 2025, $0.03 in Q2 2025, and $0.03 in Q1 2025.